| scholarly article | Q13442814 |
| P50 | author | Adriana Seber | Q57209002 |
| Jakob R. Passweg | Q67905482 | ||
| P2093 | author name string | Y Kodera | |
| J Szer | |||
| M Horowitz | |||
| J Apperley | |||
| N Novitzky | |||
| M Mohty | |||
| M Iida | |||
| J Nunez | |||
| D Niederwieser | |||
| Y Atsuta | |||
| A Gratwohl | |||
| M Aljurf | |||
| H Greinix | |||
| D Confer | |||
| H Baldomero | |||
| M Gratwohl | |||
| J Lipton | |||
| L F Bouzas | |||
| M C Pasquini | |||
| P2860 | cites work | Haploidentical hematopoietic stem cell transplantation: state of art. | Q38514481 |
| WHO Guiding Principles on Human Cell, Tissue and Organ Transplantation1 | Q56779208 | ||
| Application of SWOT analysis | Q70657465 | ||
| High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time has passed | Q83365174 | ||
| PBSC collection from family donors in Japan: a prospective survey | Q86057605 | ||
| [Hematopoietic cell transplantation in Japan: nationwide survey 2013] | Q86875994 | ||
| Hematopoietic stem cell transplantation: a global perspective | Q24624697 | ||
| Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist | Q27001349 | ||
| Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility | Q27012881 | ||
| Umbilical cord blood banking: from personal donation to international public registries to global bioeconomy | Q33800639 | ||
| Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT). | Q34330585 | ||
| Umbilical cord blood transplantation: the first 25 years and beyond | Q34344669 | ||
| The global diffusion of organ transplantation: trends, drivers and policy implications | Q34446821 | ||
| The survey on cellular and engineered tissue therapies in Europe in 2012. | Q34938449 | ||
| Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants. | Q35288778 | ||
| Hematopoietic stem-cell transplantation | Q36461248 | ||
| Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study. | Q37060673 | ||
| Characteristics of qualitative studies in influential journals of general medicine: a critical review. | Q37681971 | ||
| Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts | Q38207878 | ||
| One million haemopoietic stem-cell transplants: a retrospective observational study | Q38384271 | ||
| Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015. | Q38387292 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | stem cell transplantation | Q65592366 |
| P304 | page(s) | 778-785 | |
| P577 | publication date | 2016-02-22 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey | |
| P478 | volume | 51 |
| Q36354948 | A review of hematopoietic cell transplantation in China: data and trends during 2008-2016. |
| Q64109029 | Advances in hematopoietic stem cell transplantation in the Asia-Pacific region: the second report from APBMT 2005-2015 |
| Q92354151 | Alpha-1 Antitrypsin-Expressing Mesenchymal Stromal Cells Confer a Long-Term Survival Benefit in a Mouse Model of Lethal GvHD |
| Q91699019 | Apheresis education and certification for nurses |
| Q93126220 | Assessing Cachexia Acutely after Autologous Stem Cell Transplant |
| Q38952815 | Brazilian guidelines on hematopoietic stem cell transplantation in acute myeloid leukemia |
| Q94954577 | Building a hematopoietic cell transplantation outcomes registry in Mexico |
| Q61449036 | Care performed by family caregivers of children submitted to hematopoietic stem cell transplantation |
| Q92220276 | Correlation of T Cell Subsets and Hypercholesterolemia of the Donor and Its Association with Acute Graft-versus-Host Disease |
| Q52642082 | Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis. |
| Q90383781 | Current status and prospects of primary immunodeficiency diseases in Asia |
| Q48590297 | Current status of art mobilization in Myeloma |
| Q49791614 | De novo recipient-specific Glutathione S-transferase T1 antibody development after HLA-identical hematopoietic cell transplantation |
| Q49570612 | Detection of secondary malignancy following high-dose chemotherapy in germ cell tumors: prospects and limitations |
| Q37624593 | Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel |
| Q90428326 | Diagnosis and treatment of bronchiolitis obliterans syndrome accessible universally |
| Q91152146 | Differential admixture, human leukocyte antigen diversity, and hematopoietic cell transplantation in Latin America: challenges and opportunities |
| Q92268081 | Does Being A Cancer Patient or Family Caregiver of A Cancer Patient Affect Stem Cell Donation Awareness? |
| Q92662169 | Drop of Butyrylcholinesterase Activity after Cyclophosphamide Conditioning as a Predictive Marker of Liver Transplant-Related Complications and Its Correlation with Transplant-Related Mortality in Pediatric Hematopoietic Stem Cell Recipients |
| Q47205373 | Echinocandin prophylaxis in patients undergoing haematopoietic cell transplantation and other treatments for haematological malignancies |
| Q41489399 | Editorial: "How to Improve Cord Blood Transplantation: By Enhancing Cell Counts or Engraftment?". |
| Q58725081 | Effect of dose rate on pulmonary toxicity in patients with hematolymphoid malignancies undergoing total body irradiation |
| Q91936191 | HLA Matching in Pediatric Stem Cell Transplantation |
| Q90485045 | Haploidentical Donor Bone Marrow Transplantation for Severe Aplastic Anemia |
| Q39455760 | Hematopoietic Stem Cell Transplantation: A Bioethical Lens. |
| Q87709285 | Hematopoietic cell transplantation in MDS: undervalued and underutilized |
| Q92437786 | Hematopoietic cell transplants in Jordan: different indications from the US and EU |
| Q90450871 | In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance |
| Q57818274 | Infection Complications in Hematopoietic Stem Cells Transplant Recipients: Do Genetics Really Matter? |
| Q92259323 | Is There Still a Role for Autologous Stem Cell Transplantation for the Treatment of Acute Myeloid Leukemia? |
| Q58751499 | Is a matched unrelated donor search needed for all allogeneic transplant candidates? |
| Q89723381 | Is there no place like home for an allogeneic stem cell transplant? |
| Q61446930 | Late effects of pediatric hematopoietic stem cell transplantation on left ventricular function, aortic stiffness and myocardial tissue characteristics |
| Q38767050 | Latin America: the next region for haematopoietic transplant progress. |
| Q48297171 | NK cells produce high levels of IL-10 early after allogeneic stem cell transplantation and suppress development of acute GVHD. |
| Q90788440 | Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends |
| Q39025249 | New agents in HSC mobilization. |
| Q52804927 | One or two umbilical cord blood cell units? Caveat emptor. |
| Q96304256 | Optimal Delivery of Follow-Up Care After Allogeneic Hematopoietic Stem-Cell Transplant: Improving Patient Outcomes with a Multidisciplinary Approach |
| Q50173239 | Palliative care during and following allogeneic hematopoietic stem cell transplantation |
| Q39345522 | Patient and Caregiver Adjustment to Hematopoietic Stem Cell Transplantation: a Systematic Review of Dyad-Based Studies |
| Q55153801 | Patients' Main Concerns About Having a Sibling Stem Cell Donor - A Grounded Theory Study. |
| Q92308511 | Peripheral blood stem cell mobilization; a look ahead |
| Q54257561 | Post stem cell transplantation revaccination: A survey of the current practices in India. |
| Q48574957 | Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell |
| Q41279525 | Recombinant TAT-BMI-1 fusion protein induces ex vivo expansion of human umbilical cord blood-derived hematopoietic stem cells. |
| Q91682914 | Refractory autoimmune haemolytic anaemia following allogenic haematopoietic stem cell transplantation: successful treatment of rituximab |
| Q58121933 | Respiratory failure in the hematopoietic stem cell transplant recipient |
| Q57176528 | Role of White Blood Cells in Blood- and Bone Marrow-Based Autologous Therapies |
| Q100491041 | Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial |
| Q37160220 | Sex chromosome loss after allogeneic hematopoietic stem cell transplant in patients with hematologic neoplasms: a diagnostic dilemma for clinical cytogeneticists |
| Q48192483 | Short-term side effects and attitudes towards second donation: A comparison of related and unrelated haematopoietic stem cell donors. |
| Q89609289 | Successful Bone Marrow Recovery After an Immunoablative Regimen With Autologous Cord Blood Transplant in a Child With Idiopathic Severe Aplastic Anemia: A Case Report |
| Q92569958 | The Biological and Clinical Relevance of G Protein-Coupled Receptors to the Outcomes of Hematopoietic Stem Cell Transplantation: A Systematized Review |
| Q90193719 | The Contribution of Motor Changes to Oral Mucositis in Pediatric Cancer Patients: A Cross-Sectional Study |
| Q89748159 | The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus |
| Q91387141 | The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies |
| Q92129067 | The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation |
| Q90461947 | The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases |
| Q49724144 | The Japan Marrow Donor Program, 25 years of experience in achieving 20,000 bone marrow transplantations: organization structure, activity, and financial basis |
| Q38728327 | The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy |
| Q52678836 | The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology. |
| Q64229822 | The first hematopoietic stem cell transplantation centre in Iraqi Kurdistan: nursing perspectives and education |
| Q55307713 | The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era. |
| Q46263769 | Third International workshop on the biology, prevention, and treatment of relapse after stem cell transplantation |
| Q92741058 | Understanding the Journey of Human Hematopoietic Stem Cell Development |
| Q90999916 | Unrelated cord blood transplantation for severe aplastic anemia using intensified immunoablative conditioning regimen leading to high engraftment and survival |
| Q41909687 | Zebrafish In-Vivo Screening for Compounds Amplifying Hematopoietic Stem and Progenitor Cells: - Preclinical Validation in Human CD34+ Stem and Progenitor Cells |
Search more.